News & Press Release

  • 2020-03-25 Product Information

Marketing Approval Granted in Japan for Melatobel® Granules 0.2% for Pediatric, a Melatonin Receptor Agonist that Improves the Onset of Sleep

  1. 前の記事へ
  2. 一覧へ戻る(英語)
  3. 次の記事へ
PAGE TOP
  1. HOME
  2. News & Press Release
  3. Marketing Approval Granted in Japan for Melatobel® Granules 0.2% for Pediatric, a Melatonin Receptor Agonist that Improves the Onset of Sleep